About Biotoxtech
Biotoxtech is a publicly listed company based in Cheongju-si (South Korea) founded in 2000. Provider of preclinical services for evaluating safety and efficacy of new treatments. The company has 230 employees. Its website biotoxtech.com draws about 11 thousand monthly visits. Biotoxtech offers products and services including Toxicity Testing Services, Efficacy Evaluation, and Ecological Testing. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its legal entity is Biotoxtech Co., Ltd.
Company details
Biotoxtech is a AAALAC accredited preclinical CRO offering toxicity and efficacy testing services for the pharmaceutical, food and cosmetic industries. Their toxicity testing service includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathologyhematology, and juvenile animal toxicity studies. They also offer in vitro (primary and secondary cell-based assays, xenograft assays) and in vivo models to study efficacy of drugs targeting cancer, diabetes, obesity, arthritis, atopic diseases and hypertension. Biotoxtech also offer PKTKADME and bioanalysis services (for formulation related applications).
- Headquarters Cheongju-si, South Korea
- Employees 230
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website biotoxtech.com
- Social Facebook
- Legal Name Biotoxtech Co., Ltd.
- Annual Revenue$32.56 M (USD)13.73as on Dec 31, 2025
- Net Profit$803.21 K (USD)as on Dec 31, 2025
- EBITDA-$1.13 M (USD)64.24as on Dec 31, 2025
- Investors
- Employee Count230
Products & Services of Biotoxtech
Biotoxtech offers a comprehensive portfolio of products and services, including Toxicity Testing Services, Efficacy Evaluation, and Ecological Testing.
Evaluates toxicity of pharmaceuticals and chemicals for compliance
Assesses effectiveness of health products and cosmetics
Conducts tests for ecological impact of substances
Funding Insights of Biotoxtech
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Biotoxtech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2001 | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Biotoxtech
Biotoxtech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hyundai Venture Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| hvic.co.kr |
Investor details for Biotoxtech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Biotoxtech
Biotoxtech is a publicly listed company on the KRX with ticker symbol 086040 in South Korea, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Sep 2007
- Listed onKRX: 86040
- Listed entityBiotoxtech Co., Ltd.
- Exchange sectorCommercial services
- ISINKR7086040003
- Share price2,130.00 KRW (+1.67% on the day) · 2026-10-14
- Market capitalisation32,275,562,296.00 KRW
- Price to earnings245.0
- EPS (diluted, trailing year)-299.35 KRW
- Volume (last session)7,544
Financials of Biotoxtech
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 47.02B KRW | 1.16B KRW | -1.63B KRW |
| 2024 | 41.34B KRW | -6.43B KRW | -4.57B KRW |
| 2023 | 32.63B KRW | -4.88B KRW | -5.04B KRW |
| 2022 | 37.29B KRW | 2.73B KRW | 2.71B KRW |
| 2021 | 32.72B KRW | 7.11B KRW | 6.37B KRW |
Detailed financial statements for Biotoxtech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Biotoxtech
3 dated milestones of Biotoxtech across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Biotoxtech is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
Web traffic of Biotoxtech
The website of Biotoxtech (biotoxtech.com) receives about 11.1K visits a month and ranks #689,683 among all websites worldwide, #775 in Biotechnology and Pharmaceuticals.
- Monthly visits11.1K
▼ 53.5% vs previous month
- Unique visitors6.6K
per month
- Global rank#689,683
among all websites
- Category rank#775
Health · Biotechnology and Pharmaceuticals
- Bounce rate28%
- Pages per visit10.4
- Average visit19 min 56 sec
- DevicesDesktop 75% · Mobile 25%
Websites whose visitors overlap most with Biotoxtech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scantox.com | 100% | 21.1K | #1,404,357 | View details | |
| samsungbiologics.com | 85% | 52K | #483,833 | View details | |
| chemon.co.kr | 73% | 7K | #3,198,221 | View details | |
drug.co.kr | drug.co.kr | 62% | #2,485,121 | – | |
kobia.kr | kobia.kr | 52% | #1,570,244 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Biotoxtech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biotoxtech
Complete news archive for Biotoxtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biotoxtech
Biotoxtech was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Biotoxtech is headquartered in Cheongju-si, South Korea. It is registered at Cheongju-si, North Chungcheong, South Korea.
Biotoxtech has 230 employees.
Annual revenue of Biotoxtech is $32.56M as on Dec 31, 2025.
Biotoxtech is a AAALAC accredited preclinical CRO offering toxicity and efficacy testing services for the pharmaceutical, food and cosmetic industries. Their toxicity testing service includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathologyhematology, and juvenile animal toxicity studies. They also offer in vitro (primary and secondary cell-based assays, xenograft assays) and in vivo models to study efficacy of drugs targeting cancer, diabetes, obesity, arthritis, atopic diseases and hypertension. Biotoxtech also offer PKTKADME and bioanalysis services (for formulation related applications).
Biotoxtech offers Toxicity Testing Services, Efficacy Evaluation, and Ecological Testing.
Yes, Biotoxtech is publicly traded on KRX under the ticker symbol 086040.
Biotoxtech has 1 investor. Key investors include Hyundai Venture Investment.
Biotoxtech operates through Biotoxtech Co., Ltd..